Enlarge / Heather Bresch, chief executive officer of Mylan.Getty | Bloomberg reader comments 56 Share this story Facing public and political wrath for steep price hikes on life-saving EpiPens, the devices’ manufacturer, Mylan, announced Monday that it will offer a cheap generic. But the generic isn’t that cheap. Since Mylan bought EpiPens in 2007,...